Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT06311851
Eligibility Criteria:
Inclusion Criteria:
* Confirmation of metastatic liver cancer via histological examination or a characteristic imaging profile on dynamic computed tomography (CT) scan or magnetic resonance imaging (MRI) without indications for surgical resection
* Eastern cooperative oncology group performance status (ECOGPS) of 0 or 1
* Liver function categorized as Child-Pugh class A or B
* Stable non-hepatic metastases, such as skeletal, pulmonary, or lymph node metastases
* Hepatic tumor burden below 70%
* Expected survival duration exceeding six months
* Laboratory findings meeting specific criteria, including platelet count \>50×109 /L, hemoglobin \>8.0 g/dL, ANC count ≥1.5 × 109/L, bilirubin \<51 mmol/L, alanine and aspartate aminotransferase \<3 times the upper limit of the normal range, and serum creatinine \<1.5 times the upper limit of the normal range.
Exclusion Criteria:
* Active infection
* Presence of severe comorbidities, such as hepatic encephalopathy, refractory ascites, and esophageal variceal bleeding
* Prior liver resection
* Previous TACE therapy received at other healthcare facilities
* Poor performance status (ECOGPS \> 1)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06311851
Study Brief:
Protocol Section:
NCT06311851